5-ALA mediated photodynamic therapy induces autophagic cell death via AMP-activated protein kinase
- 8.7k Downloads
Photodynamic therapy (PDT) has been developed as an anticancer treatment, which is based on the tumor-specific accumulation of a photosensitizer that induces cell death after irradiation of light with a specific wavelength. Depending on the subcellular localization of the photosensitizer, PDT could trigger various signal transduction cascades and induce cell death such as apoptosis, autophagy, and necrosis. In this study, we report that both AMP-activated protein kinase (AMPK) and mitogen-activated protein kinase (MAPK) signaling cascades are activated following 5-aminolevulinic acid (ALA)-mediated PDT in both PC12 and CL1-0 cells. Although the activities of caspase-9 and -3 are elevated, the caspase inhibitor zVAD-fmk did not protect cells against ALA-PDT-induced cell death. Instead, autophagic cell death was found in PC12 and CL1-0 cells treated with ALA-PDT. Most importantly, we report here for the first time that it is the activation of AMPK, but not MAPKs that plays a crucial role in mediating autophagic cell death induced by ALA-PDT. This novel observation indicates that the AMPK pathway play an important role in ALA-PDT-induced autophagy.
KeywordsPC12 Cell Mitochondrial Membrane Potential Extracellular Signal Regulate Kinase AMPK Activation Autophagic Cell Death
Photodynamic therapy (PDT) has been developed as a modality for cancer treatment which combines the use of low energy light with the photosensitizer . The rapid tumor ablation by PDT involves direct cell killings as well as damage to the exposed microvasculature . Singlet oxygen as well as other reactive oxygen species are the major cytotoxic agents responsible for the PDT-induced cellular damages . Cellular and molecular mechanisms involved in PDT-mediated oxidative stress are becoming clear [4, 5]. However, the signaling pathways involved in the PDT-mediated cell death are not completely understood.
5-aminolevulinic acid (ALA) itself is not a photosensitizer and serves as the biological precursor in the heme biosynthetic pathway. Exogenous ALA administration leads to the accumulation of PpIX in the mitochondria, which causes direct mitochondrial damage and subsequent cell death after light irradiation . The integration of a complex signaling network results in either cellular repair/recovery or death. Activation of the three major mitogen activated protein kinases (MAPKs), the extracellular signal regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and the p38 kinase have been found in PDT-treated cells [4, 5]. Nevertheless, the roles of MAPKs in mediating PDT-induced cell death depend on the cell line and/or photosensitizer used.
AMP-activated protein kinase (AMPK) is a highly conserved heterotrimeric serine/threonine protein kinase that regulates energy homeostasis in mammalian cells [7, 8]. It can be activated by ATP depletion or AMP elevation . The activated AMPK can restore energy homeostasis inside cells by inhibiting anabolic reactions and stimulating energy-producing catabolic pathways. Cancer cells exhibit characteristic metabolic demands that are different from normal cells. Being a key metabolic regulator, AMPK may regulate the switch. Other than a metabolic sensor, AMPK also plays a critical role in response to cellular stress such as hypoxia or oxidative stress . In addition, activation of AMPK has been implicated in the regulation of anti-apoptotic [11, 12, 13] as well as pro-apoptotic effects [14, 15, 16]. Recent studies also indicate the involvement of AMPK in autophagy induced by stimuli such as hypoxia or nutrient-free medium [17, 18, 19]. These observations imply that AMPK may be a potential target for cancer treatment.
Autophagy is involved in removing damaged organelles, a process that is required for the promotion of cellular survival during nutrient starvation, pathogen infection, aging, and neurodegenerative processes [20, 21]. However, the constitutive activation of autophagy can lead to cell death as a result of excessive self-destruction of cellular organelles . PDT-treated cells can undergo apoptotic or nonapoptotic pathways, depending on the cell type, the photosensitizer, and the PDT dose [5, 23]. Recently, PDT-induced autophagy has also been described [5, 24]. However, the signaling molecule involved in PDT-induced autophagy is not clear.
Previously, we have shown that ALA mediated PDT could disrupt mitochondrial membrane potential, deplete cellular ATP and hence, cause mitochondrial dysfunction . Since autophagy is a common response to mitochondrial dysfunction , we reasoned that ALA-PDT may induce autophagic cell death by interfering with cellular bioenergetics. In this study, we demonstrate that ALA-PDT can trigger autophagic cell death by the regulation of AMPK. Our results indicate that AMPK activation is required for ALA-PDT induced autophagic cell death.
Cell death induced by ALA-PDT involves the activation of AMP-activated protein kinase
ALA-PDT induces caspase-independent cell death
Autophagy is the main cell death mode following ALA-PDT
AMPK, but not JNK nor p38, mediates autophagic cell death following ALA-PDT
We have demonstrated that the activation of AMPK was associated with ALA-PDT-induced cell death (Fig. 2). To investigate whether AMPK activation mediates ALA-PDT-induced autophagic cell death, the expression level of autophagic marker LC3-II was examined in the absence or presence of Compound C. As shown in Fig. 5C, Compound C inhibited the formation of LC3-II in both PC12 and CL1-0 cells treated with ALA-PDT, indicating that ALA-PDT induced autophagic cell death is mediated by AMPK.
The commitment events as well as the modality of cell death induced by PDT have been extensively studied. It is widely agreed that the action mechanism of PDT is largely dependent on (1) the preferential subcellular localization of the photosensitizer, (2) the molecular targets of the photosensitizer, and (3) the genotype of the cell. Although caspase-dependent apoptosis has been documented as the predominant cell death modality after PDT [5, 29, 38, 39, 40], recent studies have also demonstrated that PDT may induce non-apoptotic cytotoxicity via the induction of autophagic cell death pathway [24, 41]. In this study, we observed that PC12 and CL1-0 cells underwent autophagy after ALA-PDT as indicated by multiple independent approaches that either revealed the formation of autophagic vacuoles or the expression of autophagy specific proteins (Fig. 4). In addition, the cell death was prevented by the autophagy inhibitor but not the caspase antagonist (Fig. 5). These results led to our conclusion that autophagy is the predominant form of cell death in both PC12 and CL1-0 cells in response to ALA-PDT. However, it should be noted that the autophagy inhibitor (3-MA) could not fully rescue the ALA-PDT-induced cell death and also partially decreased the activity of caspase-9 and -3 (Fig. 5A and 5B, right panel). These observations might relate to the loss of mitochondrial membrane potential (MMP) induced by ALA-PDT. It is possible that subsequent to the loss of MMP, cytochrome c released from mitochondria might still induce the activation of caspase-9 and caspase-3, although caspase activation in this fashion did not play a role in ALA-PDT mediated cell death. In addition, other cell death regulators, such as apoptosis-inducing factor (AIF) and the endonuclease G might be released from the mitochondria as a result of MMP breakdown. These molecules could further lead to caspase-independent DNA fragmentation , which explains the oligonucleosomal DNA fragmentation induced by ALA-PDT (Fig. 3A). This notion could be further supported by the findings of Furre et al.  that showed that PpIX-mediated mitochondrion-photosensitization induces apoptosis through translocation of AIF in human leukemia cells. In this regard, we still cannot rule out the possibility that, other than autophagy, ALA-PDT might induce other modes of caspase-independent cell death in PC12 and CL1-0 cells. Further investigations are required to fully characterize the concomitant mediators and determinant switches of other minor types of cell death that might coexist in PC12 and CL1-0 cells in response to ALA-PDT.
Although PDT-induced stress-activated pathways linked to cell death have been explored widely, direct biochemical associations between the stress signals and cell death, especially autophagy, remain poorly characterized. Activation of the three MAPKs has been described in various cell lines following PDT. However, the role of AMPK had not been reported in PDT biology. In an attempt to identify the major molecular event(s) required for autophagic cell death induced by ALA-PDT, we evaluated the activity of AMPK and MAPK protein kinase families in PC12 and CL1-0 cells. We found that the activation of AMPK and JNK and p38 was one of the earliest molecular events involved in the ALA-PDT-induced cell death. Significant activation of JNK and p38 was found to precede the activation of AMPK after ALA-PDT in both PC12 and CL1-0 cell lines. Nevertheless, AMPK and MAPK are independent effectors of ALA-PDT because further studies showed that the level of AMPK activation remained unaffected by the MAPK blockers (Fig. 6C). Vice versa, inhibition of AMPK did not alter the activation level of MAPKs induced by ALA-PDT in PC12 and CL1-0 cells (data not shown).
Although the activation of MAPK signaling could induce autophagy , MAPKs are not involved in mediating autophagic cell death in ALA-PDT treated cells because the formation of autophagy specific LC3-II protein remained unaltered in response to the treatment of JNK and p38 inhibitors (Fig. 6D). Conversely, the AMPK inhibitor could effectively prevent the cell death after ALA-PDT and could reduce the expression level of autophagy-associated LC3-II protein. These results together provide a novel yet intriguing link between AMPK signaling cascade and autophagic cell death triggered by ALA-PDT. Based on these results, we conclude that autophagic cell death induced by ALA-PDT requires the activation of AMPK but not MAPKs in both PC12 and CL1-0 cells. Although JNK and p38 are not involved in the ALA-PDT-induced autophagic cell death (Fig. 6B), it should be noted that the combination of AMPK and p38 inhibitors has additive effect in increasing the cell survival after ALA-PDT compared to the AMPK or p38 inhibitor alone (Fig. 7). Together, these data further demonstrate that MAPKs and AMPK are independent pathways involved in ALA-PDT-induced cell death.
Our investigations reported in this article have revealed the novel association of the activation of AMPK to ALA-PDT-induced autophagic cell death. These findings shed light on the development of new anticancer therapeutic modality. However, the complex picture of multiple signaling cascades that link PDT-induced oxidative stress to the ultimate autophagic cell death remains far from complete. Further characterization of the intermediating mechanisms may reveal novel therapeutic strategy in anti-cancer treatment.
In this study, we found that ALA-PDT effectively induced oxidative stress that led to immediate mitochondrial dysfunction, and finally resulted in a caspase-independent cell death in PC12 and CL1-0 cells. In response to ALA-PDT, activation of AMPK, JNK, and p38 signaling cascades were found to promote cell death. However, it was the activation of AMPK but not JNK or p38 that mediated autophagic cell death in PC12 and CL1-0 cells. These results indicate the involvement of AMPK and p38 pathways in this complex mechanism.
Materials and methods
Chemical reagents and antibodies
ALA, N-acetyl-L-cysteine (NAC), and monodansylcadaverine (MDC) and 3-methyladenine (3-MA) were purchased from Sigma (St. Luis, MO, USA). 5,5',6,6'-tetrachloro-1,1',3,3'- tetraethylbenzimida- zolylcarbocyanine iodide (JC-1) and ATP determination kit were purchased from Molecular Probes (Eugene, OR, USA). Lipofectamine 2000 transfection kit and Trypan Blue were purchased from Invitrogen (Carlsbad, CA, USA). Antibodies to phosphorylated ERK, p38, and AMPK or total ERK, JNK and p38 were purchased from Cell Signaling Technology (Danvers, MA, USA). Anti-phospho-JNK antibody, Caspase-3/CPP32 and Caspase-9 fluorometric assay kits were purchased from BioVision (Mountain View, CA, USA). Monoclonal antibody that recognizes both forms of LC3 was purchased from MBL International Cooperation (Woburn, MA, USA). PD98059 and SB203580 were purchased from Promega. SP600125, Compound C and zVAD-fmk (Z-Val-Ala-Asp(OMe)-fluoromethyl ketone) were obtained from Calbiochem (San Diego, CA, USA).
Cell culture, transfection, and photodynamic treatment
PC-12 cells were incubated in DMEM supplemented with 5% fetal bovine serum (FBS) and 10% heat-inactivated horse serum (HS). CL1-0 cells were derived from a poorly differentiated human lung adenocarcinoma  and cultured in RPMI medium containing 10% FBS. Cells were cultured at 37°C in a humidified atmosphere containing 5% CO2. The GFP-LC3 transfected PC12 cells were produced by transfecting pGFP-LC3 plasmid into subconfluent PC12 cells using Lipofectamine 2000 transfection kit. For ALA-PDT, cells were seeded onto culture dishes or chamber slides and grown overnight in complete medium. Unless otherwise specified, cells were then incubated with 1 mM ALA for 3 hr, and then exposed to various doses of light. The light source is consisted of high power LED array, with the wavelength centered at 635 ± 5 nm . The light dose is 1-6 J/cm2 (PC12) or 12 J/cm2 (CL1-0) at an intensity of 60 mW/cm2. After irradiation, cells were incubated in complete medium until further analyzed.
Cell survival rate
After ALA-PDT, cellular cytotoxicity was determined by Trypan Blue exclusion assay. Briefly, cells were trypsinized 24 hr post ALA-PDT and co-incubated with 0.4% (w/v) Trypan Blue at room temperature for 10 min. Cells with Trypan blue uptake were counted as dead cells on a hemacytometer. Cells exposed to ALA without light irradiation were used as controls. Each individual phototoxic experiment was repeated for three times.
Analysis of mitochondrial membrane potential
Prior to examine the mitochondrial membrane potential, cells were seeded into chamber slides and allow growing for 24 hr. On the next day, cells were incubated with 1 mM ALA for 3 hr. For the last 20 min of ALA incubation, cells were stained with 10 μg/ml of JC-1 for the examination of mitochondrial membrane potential. After light irradiation, JC-1 staining patterns were visualized with the confocal spectral microscope (Leica, model TCS SP2). JC-1 was excited by a 488 nm agron-ion laser and the emitted fluorescence was measured at 525 ± 20 nm for JC-1 monomers and 615 ± 25 nm for JC-1 aggregates. All experiments were performed under ambient light.
Determination of mitochondrial ATP content
Mitochondrial ATP content was measured with an ATP determination kit according to manufacturer's instructions (Molecular Probes, Eugene, OR, USA). Briefly, cells were plated and incubated in glucose-free culture medium for 3 hr to avoid the production of ATP via glycolysis. At the time indicated after ALA-PDT, cells were lysed with 1% Triton and mixed with ATP reaction buffer before measuring the luminescence by a luminescence counter. The relative luminescence intensities were corrected with the amount of total protein in the cell extract. Three measurements were taken from each sample for statistical analysis.
Assays of DNA fragmentation and caspase enzymatic activity
For DNA fragmentation analysis, PC12 cells were returned to the complete medium after ALA-PDT and cell pellets were collected at the time indicated. DNA from the cell pellets was isolated with QIAamp DNA Mini kit according to the manufacturer's instructions (Qiagen, Valencia, CA, USA) before further analyzed in a 1.5% agarose gel. After electrophoresis, the gel was stained with 0.5 μg/ml ethidium bromide and photographed under UV light. For caspase activity, PC12 & CL1-0 cells were seeded into Petri-dishes. After ALA-PDT, cells were returned to the complete medium and cell lysates were collected at the time indicated to determine the caspase-9 and -3 like activities by the assay kit used according to manufacturer's instructions.
Fluorescence imaging of MDC and GFP-LC3
PC12 or GFP-LC3 transfected PC12 cells were seeded into Chamber Slides and incubated for 24 hr. On the next day, cells were treated with ALA-PDT. At the time indicated, PC12 cells were stained with 0.05 mM MDC in PBS for the imaging of autophagosomes. To detect the re-distribution of GFP-LC3 after ALA-PDT, GFP-LC3 transfected PC12 cells were fixed and co-stained with Hoechst 33342 to label the nucleus. Cells were then washed with PBS and immediately observed under microscope. The MDC fluorescence images were taken under Zeiss Axiophot 2 Fluorescence Microscope. The fluorescence photographs of LC3-GFP were recorded upon excitation by a 488 nm agron-ion laser and the emission measured at 525 ± 25 nm using the confocal fluorescence microscope (Leica TCS SP5). A Diode UV laser (405 nm) was used to excite Hoechst 33342 and the emitted fluorescence was collected at 445 ± 15 nm.
Cells treated with ALA-PDT were lysed at the time indicated. Equal amount of protein lysates were electrophoresed on 10% SDS-polyacrylamide gels. The proteins were transferred to the nitrocellulose membrane and incubated with antibodies recognizing both form of LC-3, phosphorylated form of ERKs, JNK, p38, AMPK proteins or β-actin (as loading control). We also determined the total amount of ERK, JNK and P38 using antibodies specific to all forms of ERK, JNK and p38, respectively. Secondary antibody conjugated with horseradish peroxidase was applied and immunocomplex was visualized by Chemiluminescence Reagent Plus (Blossom Biotechnology Inc., Boston, USA).
All experiments were repeated at least three times with 4~6 parallel measurements in different dishes or slides. Results were averaged from experiments performed under the same conditions and described as the mean ± SD unless stated otherwise. The statistical significance of differences in the results was analyzed using Student's t-test for paired experiment or one-way ANOVA test for multiple comparisons.
The authors thank Professor Tamotsu Yoshimori (Research Institute for Microbial Diseases, Osaka University, Osaka, Japan) for his kind gift of the GFP-LC3 construct. We thank Miss Chia-Yi Tseng and Pei-Shin Fang for her assistance in the experiment. This work was supported by the National Science Council (NSC 95-2320-B-002-101 & NSC 97-2320-B-002-032-MY2), Taiwan.
- 12.Russell RR, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH: AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest. 2004, 114: 495-503.PubMedCentralCrossRefPubMedGoogle Scholar
- 13.Stefanelli C, Stanic I, Bonavita F, Flamigni F, Pignatti C, Guarnieri C, Caldarera CM: Inhibition of glucocorticoid-induced apoptosis with 5-aminoimidazole-4-carboxamide ribonucleoside, a cell-permeable activator of AMP-activated protein kinase. Biochem Biophys Res Commun. 1998, 243: 821-826. 10.1006/bbrc.1998.8154CrossRefPubMedGoogle Scholar
- 16.Meisse D, Casteele Van de M, Beauloye C, Hainault I, Kefas BA, Rider MH, Foufelle F, Hue L: Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells. FEBS Lett. 2002, 526: 38-42. 10.1016/S0014-5793(02)03110-1CrossRefPubMedGoogle Scholar
- 17.Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL: The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol. 2007, 9: 218-224. 10.1038/ncb1537CrossRefPubMedGoogle Scholar
- 29.Ji Z, Yang G, Vasovic V, Cunderlikova B, Suo Z, Nesland JM, Peng Q: Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. J Photochem Photobiol B. 2006, 84: 213-220. 10.1016/j.jphotobiol.2006.03.006CrossRefPubMedGoogle Scholar
- 39.Furre IE, Shahzidi S, Luksiene Z, Moller MT, Borgen E, Morgan J, Tkacz-Stachowska K, Nesland JM, Peng Q: Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res. 2005, 65: 11051-11060. 10.1158/0008-5472.CAN-05-0510CrossRefPubMedGoogle Scholar
- 41.Buytaert E, Callewaert G, Hendrickx N, Scorrano L, Hartmann D, Missiaen L, Vandenheede JR, Heirman I, Grooten J, Agostinis P: Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J. 2006, 20: 756-758.PubMedGoogle Scholar
- 43.Corcelle E, Nebout M, Bekri S, Gauthier N, Hofman P, Poujeol P, Fenichel P, Mograbi B: Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity. Cancer Res. 2006, 66: 6861-6870. 10.1158/0008-5472.CAN-05-3557CrossRefPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.